Critical Comparison: Impax Laboratories


Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations. Innocoll has lower revenue, but higher earnings than Impax Laboratories.



from Biotech News